Changes in oscillatory impedance and nitrogen washout with combination fluticasone/salmeterol therapy in COPD

Respiratory Medicine

Volumn 108, Issue 2, 2014, Pages 344-350

  Timmins, Sophie C ^a,b,c,d   Diba, Chantale ^a,d   Schoeffel, Robin E ^a,b,c   Salome, Cheryl M ^a,c,d   King, Gregory G ^a,b,c,d   Thamrin, Cindy ^a  

^a WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d Cooperative Research Centre for Asthma and Airways ^*  (Australia)

Author keywords

COPD; Forced oscillation technique; Physiology; Therapy

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL;

ADULT; AGED; ARTICLE; BREATHING MECHANICS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FORCED EXPIRATORY VOLUME; FORCED OSCILLATION TECHNIQUE; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG VENTILATION; MEASUREMENT; METERED DOSE INHALER; NITROGEN WASHOUT; OSCILLATION; PRIORITY JOURNAL; RESPIRATORY TRACT PARAMETERS; SMALL AIRWAY FUNCTION; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TREATMENT RESPONSE;

COPD; FORCED OSCILLATION TECHNIQUE; PHYSIOLOGY; THERAPY;

ADMINISTRATION, INHALATION; AGED; ALBUTEROL; ANALYSIS OF VARIANCE; ANDROSTADIENES; BRONCHI; BRONCHODILATOR AGENTS; DRUG COMBINATIONS; GLUCOCORTICOIDS; HUMANS; LONGITUDINAL STUDIES; NITROGEN; OSCILLOMETRY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS;

EID: 84893730939     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.10.004     Document Type: Article

References (37)

1. Global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD) 2011. Available from: http://www.goldcopd.org/.
2. P.M. Calverley, J.A. Anderson, B. Celli, G.T. Ferguson, C. Jenkins, and P.W. Jones et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 8 2007 Feb 22 775 789
3. W. Szafranski, A. Cukier, A. Ramirez, G. Menga, R. Sansores, and S. Nahabedian et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease Eur Respir J 21 1 2003 Jan 74 81
4. J.A. Wedzicha, P.M. Calverley, T.A. Seemungal, G. Hagan, Z. Ansari, and R.A. Stockley The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide Am J Respir Crit Care Med 177 1 2008 Jan 1 19 26
5. N.A. Hanania, G.D. Crater, A.N. Morris, A.H. Emmett, D.M. O'Dell, and D.E. Niewoehner Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD Respir Med 106 1 2012 Jan 91 101
6. J.A. Guenette, N. Raghavan, V. Harris-McAllister, M.E. Preston, K.A. Webb, and D.E. O'Donnell Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD Respir Med 105 12 2011 Dec 1836 1845
7. R.L. Dellaca, P. Santus, A. Aliverti, N. Stevenson, S. Centanni, and P.T. Macklem et al. Detection of expiratory flow limitation in COPD using the forced oscillation technique Eur Respir J 23 2 2004 Feb 232 240
8. M.K. Johnson, M. Birch, R. Carter, J. Kinsella, and R.D. Stevenson Measurement of physiological recovery from exacerbation of chronic obstructive pulmonary disease using within-breath forced oscillometry Thorax 62 4 2007 Apr 299 306
9. Z.L. Borrill, C.M. Houghton, A.A. Woodcock, J. Vestbo, and D. Singh Measuring bronchodilation in COPD clinical trials Br J Clin Pharmacol 59 4 2005 Apr 379 384
10. R.L. Dellaca, P.P. Pompilio, P.P. Walker, N. Duffy, A. Pedotti, and P.M.A. Calverley Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD Eur Respir J 33 6 June 1, 2009 1329 1337
11. C.M. Houghton, N. Lawson, Z.L. Borrill, C.L. Wixon, S. Yoxall, and S.J. Langley et al. Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma Respir Res 8 2007 52
12. M. Yamaguchi, A. Niimi, T. Ueda, M. Takemura, H. Matsuoka, and M. Jinnai et al. Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry Pulm Pharmacol Ther 22 4 2009 Aug 326 332
13. M. Cosio, H. Ghezzo, J. Hogg, R. Corbin, M. Loveland, and J. Dosman et al. The relations between structural changes in small airways and pulmonary-function tests N Engl J Med 298 23 June 8, 1978 1277 1281
14. S.C. Timmins, N. Coatsworth, G. Palnitkar, C. Thamrin, C.E. Farrow, and R.E. Schoeffel et al. Day-to-day variability of oscillatory impedance and spirometry in asthma and COPD Respir Physiol Neurobiol 185 2 2013 Jan 15 416 424
15. S. Verbanck, D. Schuermans, A. Van Muylem, C. Melot, M. Noppen, and W. Vincken et al. Conductive and acinar lung-zone contributions to ventilation inhomogeneity in COPD Am J Respir Crit Care Med 157 5 May 1, 1998 1573 1577
16. S. Verbanck, D. Schuermans, M. Meysman, M. Paiva, and W. Vincken Noninvasive assessment of airway alterations in smokers: the small airways revisited Am J Respir Crit Care Med 170 4 2004 Aug 15 414 419
17. S. Verbanck, D. Schuermans, and W. Vincken Small airways ventilation heterogeneity and hyperinflation in COPD: response to tiotropium bromide Int J Chron Obstruct Pulmon Dis 2 4 2007 625 634
18. P.W. Jones, F.H. Quirk, and C.M. Baveystock The St George's respiratory questionnaire Respir Med 85 Suppl. B 1991 Sep 25 31 [discussion 3-7]
19. D.A. Mahler, D.H. Weinberg, C.K. Wells, and A.R. Feinstein The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes Chest 85 6 1984 Jun 751 758
20. N.J. Brown, W. Xuan, C.M. Salome, N. Berend, M.L. Hunter, and A.W. Musk et al. Reference equations for respiratory system resistance and reactance in adults Respir Physiol Neurobiol 172 3 2010 162 168 10.1016/j.resp.2010.05.013
21. E. Oostveen, D. MacLeod, H. Lorino, R. Farre, Z. Hantos, and K. Desager et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments Eur Respir J 22 6 2003 Dec 1026 1041
22. P.D. Robinson, M. Turner, N.J. Brown, C. Salome, N. Berend, and G.B. Marks et al. Procedures to improve the repeatability of forced oscillation measurements in school-aged children Respir Physiol Neurobiol 177 2 2011 199 206
23. N.S.C. Brown, G. King, M. Hunter, A.W. Musk, and A.L. James Reference equations for impedence parameters measured by the forced oscillation technique Respirology 14 Suppl. 1 2009 A45
24. M.R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, and A. Coates et al. Standardisation of spirometry Eur Respir J 26 2 2005 Aug 319 338
25. N. Macintyre, R.O. Crapo, G. Viegi, D.C. Johnson, C.P. van der Grinten, and V. Brusasco et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung Eur Respir J 26 4 2005 Oct 720 735
26. J.L. Hankinson, J.R. Odencrantz, and K.B. Fedan Spirometric Reference values from a sample of the general U.S. Population Am J Respir Crit Care Med 159 1 January 1, 1999 179 187
27. R.O. Crapo, and A.H. Morris Standardized single breath normal values for carbon monoxide diffusing capacity Am Rev Respir Dis 123 2 1981 Feb 185 189
28. R.O. Crapo, A.H. Morris, and R.M. Gardner Reference spirometric values using techniques and equipment that meet ATS recommendations Am Rev Respir Dis 123 6 1981 Jun 659 664
29. S.R. Downie, C.M. Salome, S. Verbanck, B. Thompson, N. Berend, and G.G. King Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation Thorax 62 8 2007 Aug 684 689
30. Z.L. Borrill, C.M. Houghton, R. Tal-Singer, S.R. Vessey, I. Faiferman, and S.J. Langley et al. The use of plethysmography and oscillometry to compare long-acting bronchodilators in patients with COPD Br J Clin Pharmacol 65 2 2008 Feb 244 252
31. M. John, S. Bosse, U. Oltmanns, A. Schumacher, and C. Witt Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease Respir Med 99 11 2005 Nov 1418 1424
32. A. Lindberg, Z. Szalai, T. Pullerits, and E. Radeczky Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction Respirology 12 5 2007 Sep 732 739
33. D.E. O'Donnell, T. Fluge, F. Gerken, A. Hamilton, K. Webb, and B. Aguilaniu et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD Eur Respir J 23 6 2004 Jun 832 840
34. B. Celli, R. ZuWallack, S. Wang, and S. Kesten Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes Chest 124 5 2003 Nov 1743 1748
35. M. Johnson, and S. Rennard Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD Chest 120 1 2001 Jul 258 270
36. N.J. Stevenson, P.P. Walker, R.W. Costello, and P.M. Calverley Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease Am J Respir Crit Care Med 172 12 2005 Dec 15 1510 1516
37. R.L. Dellaca, A. Gobbi, M. Pastena, A. Pedotti, and B. Celli Home monitoring of within-breath respiratory mechanics by a simple and automatic forced oscillation technique device Physiol Meas 31 4 2010 Apr N11 N24